Sumitomo Seika Chemicals (4008) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
20 Jul, 2026Executive summary
Net sales for 2Q FY2024 were ¥74.0B (up 6.2% YoY), while for the six months ended September 30, 2025, net sales were ¥72,705 million (down 1.7% YoY); operating profit increased 29.8% YoY to ¥4.9B and 19.9% to ¥5,881 million, respectively.
Profit attributable to owners of the parent was ¥3.3B (up 16.2% YoY) in 2Q FY2024, but declined 1.6% to ¥3,275 million for the six months due to additional provisions for mischarging expenses.
Comprehensive income surged 232% YoY to ¥4,272 million.
Full-year forecasts anticipate continued growth in net sales and operating profit, mainly from super absorbent polymers and electronics gases, but profit outlook is reduced due to one-time charges.
Financial highlights
2Q FY2024 net sales: ¥74.0B (+6.2% YoY); operating profit: ¥4.9B (+29.8% YoY); net profit: ¥3.3B (+16.2% YoY).
Gross profit increased to ¥16,236 million from ¥14,925 million YoY.
ROE improved to 3.5% (+0.3pt YoY); ROIC rose to 3.3% (+0.6pt YoY); full-year ROIC forecast at 7.3%.
Full-year FY2024 forecast: net sales ¥147.0B (+2.8% YoY), operating profit ¥10.0B (+4.9% YoY), net profit ¥7.0B (+13.5% YoY); another forecast: net sales ¥145,000 million (-1.7% YoY), operating profit ¥11,300 million (+5.5%), net profit ¥4,400 million (-26.2%).
Basic earnings per share was ¥249.85, nearly flat YoY; full-year projection is ¥336.90.
Outlook and guidance
Net sales and operating profit expected to rise for FY2024, supported by increased sales volumes and favorable FX trends, but profit outlook is reduced due to restructuring and mischarging provisions.
Dividend forecast is unchanged at ¥200 per share for the full year.
Super absorbent polymers segment to see strong growth; functional materials segment expected to decline due to lower IR latex sales and higher fixed costs.
Latest events from Sumitomo Seika Chemicals
- Ambitious 2045 vision and FY2030 targets set, with focus on sustainability and capital efficiency.4008
Investor presentation6 Aug 2026 - Strong sales and profit growth, but FY2027 outlook tempered by rising costs and global risks.4008
Q1 20276 Aug 2026 - Sales and operating profit rose, but profit fell on one-time losses; outlook cautious.4008
Q4 202520 Jul 2026 - Profits and shareholder returns rose, but outlook is uncertain due to Middle East risks.4008
Q4 202620 Jul 2026 - Operating profit up 19.9% despite 1.7% sales drop; profit hit by mischarging provision.4008
Q2 202620 Jul 2026 - Profits fell sharply on lower sales and business exits, but full-year profit is forecast to recover.4008
Q1 202520 Jul 2026 - Profits surged on strong polymer sales and FX gains, prompting an upward revision to forecasts.4008
Q3 202520 Jul 2026 - Profits fell sharply year-over-year, but full-year net profit is forecast to rise on one-time factors.4008
Q1 202620 Jul 2026 - Operating profit rose 18.7% despite lower sales, with full-year profit forecast revised upward.4008
Q3 202620 Jul 2026